Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2011

Jun 23, 2011

34519_dirs_2011-06-23_766b0f5f-60de-4a13-b802-1eafa0d66b95.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2011-06-21

Reporting Person: Tomsche David Scott (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-06-21 Common Stock ($0.10) P 785 $6.24 Acquired 34258 Indirect
2011-06-21 Common Stock ($0.10) P 775 $6.25 Acquired 35033 Indirect
2011-06-21 Common Stock ($0.10) P 762 $6.24 Acquired 35795 Indirect

Footnotes

F1: Purchased for the Roth account of Carson Tomsche, Dr. Tomsche's son.

F2: Purchase for the Roth account of Morgan Tomsche, Dr. Tomsche's daughter.

F3: Purchased for the IRA account of Mollly Tomsche, Dr. Tomsche's spouse.